Effect of ACT-451840 Against Early Plasmodium Falciparum Blood Stage Infection in Healthy Subjects
Status:
Completed
Trial end date:
2014-07-01
Target enrollment:
Participant gender:
Summary
This was a single-center study using induced blood stage malaria infection to characterize
the activity of ACT-451840 against early Plasmodium falciparum blood stage infection